Cancer News and Research

Latest Cancer News and Research

Caspase-14 protein protects skin against UVB and dehydration

Ultraviolet rays can be harmful to our skin and pave the way to the onset of skin cancers.

22 May 2007

Breast MRI may have a role in evaluation of newly diagnosed breast cancers

Among women who are newly diagnosed with breast cancer, magnetic resonance imaging (MRI) of the breast appears helpful in determining surgical treatment, according to a report in the May issue of Archives of Surgery, one of the JAMA/Archives journals.

22 May 2007

New breast cancer treatment may dispense with the need for chemotherapy

According to the latest research new hormone therapy drugs designed to treat breast cancer may dispense with the need for chemotherapy thus avoiding the nasty side effects associated with the treatment.

21 May 2007

Suicide gene therapy kills bowel cancer cells

An innovative type of gene therapy has for the first time succeeded in making bowel cancer cells commit suicide, according to a report in Cancer Research.

20 May 2007

Hormone treatment could cut need for chemo in some younger breast cancer patients

Around 5,500 pre-menopausal breast cancer patients could be offered a hormone drug that is shown to be as effective as traditional chemotherapy - and so avoid potential infertility and long-term menopausal side effects - according to a Cancer Research UK report published in The Lancet.

20 May 2007

Ulcerative colitis disruptive in relationships

Nearly three out of four ulcerative colitis (UC) sufferers (73 percent) responding to a new nationwide survey say not feeling well has become a normal part of life.

18 May 2007

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

New updated results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS) were presented by Dr. Alan List, from the H. Lee Moffitt Cancer Center & Research Institute, at the 9th International Symposium on MDS currently taking place in Florence, Italy.

18 May 2007

Demand for VScan diagnostic test kits increases

Medical Services International Inc (Pink Sheets: MSITF) wishes to announce that as the mosquito season begins in different parts of the world; demand for the VScan diagnostic test kits that detect mosquito borne diseases is increasing. In particular, the demand is for VScan test kits that detect Malaria, Dengue Fever and West Nile.

18 May 2007

Study breaks link between lycopene and prostate cancer prevention

Tomatoes might be nutritious and tasty, but don't count on them to prevent prostate cancer.

18 May 2007

Natural immune-control system may aid treatment of autoimmune disease and tissue rejection

The immune system's ability to police itself may offer a new method of arresting the cells responsible for autoimmune diseases such as multiple sclerosis and for the rejection of transplanted organs and tissues, scientists at Dana-Farber Cancer Institute report in a study in the May issue of the journal Immunity.

18 May 2007

Lipoic acid appears to slow down the process of aging

Researchers have identified the mechanism of action of lipoic acid, a remarkable compound that in animal experiments appears to slow down the process of aging, improve blood flow, enhance immune function and perform many other functions.

18 May 2007

Hair relaxers not associated with increased risk of breast cancer in black women

Hair dye use has been associated with an increased risk of various cancers in some studies, but these results have generally not been confirmed. The present study is the first to assess hair relaxers in relation to a cancer.

18 May 2007

Substantial number of American adults hold fatalistic beliefs about cancer

If you feel that you are fated for cancer, your belief could turn into a self-fulfilling prophecy.

18 May 2007

Computer science sheds light on animal development

By applying the techniques of computer engineering to a mechanistic diagram describing the development of the Nematode C. elegans, a group of researchers in Switzerland has been able to tease out what laboratory experiments have not how and when the crucial cross-talk between cellular signaling pathways takes place in order to determine the fates of individual cells.

18 May 2007